Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alterity Therapeutics (ATHE) Intangibles (2016 - 2018)

Alterity Therapeutics has reported Intangibles over the past 4 years, most recently at $7836.2 for Q4 2018.

  • For Q4 2018, Intangibles changed N/A year-over-year to $7836.2; the TTM value through Dec 2018 reached $7836.2, changed N/A, while the annual FY2018 figure was $12174.1, 31.59% down from the prior year.
  • Intangibles for Q4 2018 was $7836.2 at Alterity Therapeutics, down from $12174.1 in the prior quarter.
  • Over five years, Intangibles peaked at $30407.6 in Q2 2015 and troughed at $7836.2 in Q4 2018.
  • A 4-year average of $18327.2 and a median of $17796.2 in 2017 define the central range for Intangibles.
  • Biggest five-year swings in Intangibles: decreased 22.97% in 2016 and later plummeted 31.59% in 2018.
  • Year by year, Intangibles stood at $30407.6 in 2015, then fell by 22.97% to $23422.0 in 2016, then fell by 24.02% to $17796.2 in 2017, then crashed by 55.97% to $7836.2 in 2018.
  • Business Quant data shows Intangibles for ATHE at $7836.2 in Q4 2018, $12174.1 in Q2 2018, and $17796.2 in Q2 2017.